Re: 'Availability of drugs and resistance testing for BPaLM regimen for rifampicin-resistant tuberculosis in Europe' by Lange et al.

Inna FriesenFrancesca SaluzzoRamona GroenheitAlexandra AubryRichard AnthonyStefan NiemannVanessa MathysDaniela Maria Cirillonull null

Published in: Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases (2024)

Keyphrases

mycobacterium tuberculosis
pulmonary tuberculosis
hiv aids
drug induced
adverse drug
hiv infected